Your browser doesn't support javascript.
loading
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer.
Kyi, Chrisann; Doubrovina, Ekaterina; Zhou, Qin; Kravetz, Sara; Iasonos, Alexia; Aghajanian, Carol; Sabbatini, Paul; Spriggs, David; O'Reilly, Richard J; O'Cearbhaill, Roisin E.
Afiliación
  • Kyi C; Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Doubrovina E; Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Zhou Q; Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kravetz S; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Iasonos A; Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Aghajanian C; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sabbatini P; Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Spriggs D; Medicine, Weill Cornell Medical College, New York, New York, USA.
  • O'Reilly RJ; Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • O'Cearbhaill RE; Medicine, Weill Cornell Medical College, New York, New York, USA.
J Immunother Cancer ; 9(8)2021 08.
Article en En | MEDLINE | ID: mdl-34433633
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas WT1 / Carcinoma Epitelial de Ovario Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas WT1 / Carcinoma Epitelial de Ovario Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos